[Form 4] INCYTE CORP Insider Trading Activity
Incyte (INCY) reported an insider transaction by its EVP & General Counsel.
Rhea-AI Filing Summary
Incyte (INCY) reported an insider transaction by its EVP & General Counsel. On 10/15/2025, the officer exercised 277 employee stock options at a $64.25 exercise price and sold 277 shares of common stock at $85.13.
Following the transactions, the officer beneficially owned 26,569 shares directly, which includes an aggregate of 25,913 shares issuable from previously reported unvested RSUs and earned performance units. Derivative securities beneficially owned after the transactions totaled 9,161 options. The reported option grant expires on 07/14/2034 and vests in installments as disclosed.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 277 shares ($6K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Denton Sheila A.
Role
EVP & General Counsel
Sold
277 shs ($24K)
Approx. gross sale proceeds
$24K
Approx. exercise cost
$18K
Approx. pre-tax spread
$6K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 277 | $0.00 | $0.00 |
| Exercise | Common Stock | 277 | $64.25 | $18K |
| Sale | Common Stock | 277 | $85.13 | $24K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 9,161 contracts (Direct);
Common Stock — 26,569 shares (Direct)
Footnotes (2)
- F1. This includes an aggregate of 25,913 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
- F2. The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
AI-generated analysis. How Rhea-AI works. Not financial advice.